Trial NCT00925132

View at ClinicalTrials.gov 
Org. Study IDs: 200807728

Last trial update was posted on 2017-07-02

MeSH Interventions

Decitabine Panobinostat Temozolomide

MeSH Conditions

Melanoma

Other Conditions

Metastatic Melanoma

Stopping Reasons

Change in the number of approved drugs for metastatic melanoma

Limitations And Caveats

This study was closed to enrollment early as there was a change in the number of approved drugs for metastatic melanoma, making Temozolomide as a chemotherapy agent, an unlikely treatment for metastatic melanoma.

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID